Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.58M 19.47M 17.69M 33.06M 2.26B 33.22M 232M 89.69M 1.15B 88.75M 86.77M 3.68B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.74M 34.77M 31.6M 59.02M 4.04B 59.32M 414M 160M 2.05B 158M 155M 6.57B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+100.00%
Current month+61.54%
1 month+100.00%
3 months-19.23%
6 months+5.00%
Current year+27.27%
1 week 0
Extreme 0.0021
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+100.00%-40.00%+281.82% 839K
+0.53%-8.17%-37.99%-53.86% 1.75B
+0.94%-10.91% - - 1.52B
-0.41%+0.97%-24.80%+147.91% 1.15B
-0.13%-3.14%-47.34%+13.20% 1.09B
-0.21%-2.01%+216.09%+907.63% 1.05B
+1.10%+0.04%+48.63%+34.66% 969M
+1.49%+4.80%+20.35%+186.43% 798M
+1.22%-11.81%-21.94%+45.95% 716M
+3.10%-5.86%+32.60%-23.42% 523M
Average +0.73%-2.22%+16.18%+171.15% 956.71M
Weighted average by Cap. +0.62%-3.23%+18.08%+155.19%

Financials

2015 2016
Net sales 25.48M 22.19M 21.01M 19.08M 35.65M 2.44B 35.83M 250M 96.74M 1.24B 95.72M 93.59M 3.97B 32.33M 28.16M 26.65M 24.21M 45.24M 3.1B 45.46M 317M 123M 1.57B 121M 119M 5.04B
Net income 5.49M 4.79M 4.53M 4.12M 7.69M 526M 7.73M 53.95M 20.86M 267M 20.64M 20.18M 856M 2.06M 1.8M 1.7M 1.54M 2.88M 197M 2.9M 20.24M 7.83M 100M 7.74M 7.57M 321M
Net Debt 24.8M 21.6M 20.45M 18.58M 34.71M 2.38B 34.88M 244M 94.17M 1.21B 93.18M 91.11M 3.86B 18.56M 16.17M 15.3M 13.9M 25.97M 1.78B 26.1M 182M 70.46M 903M 69.72M 68.17M 2.89B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
16/09/26 US$0.002200 -48.84% 700
14/09/26 US$0.004300 +104.76% 3,750
  1. Stock Market
  2. Stocks
  3. AOXG Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!